RE:RE:RE:RE:RE:RE:RE:RE:RE:Will test. 78-.81Totally in agreement. Volume game on just weed is not very strategic.
HVT will now have top brands (based on awareness) in Delivra and Dreamwater for north america. Satipharm is established in europe and soon in North America I feel.
The "health and wellness" category will maintain profit margins and the weed commodity for recreational will decline.
HVT is being built from the ground up foudationally to be more "health and wellness" focused which will lead to higher earnings...IMHO